$RLAY

Relay Therapeutics, Inc.

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA

RLAY chart

What traders are saying about $RLAY

Latest posts

Relay Therapeutics, Inc. news

Relay Therapeutics, Inc. key financials

USD2025202420232022
Revenue$15.4M$10.0M$25.5M$1.4M
Net income-$276.5M-$337.7M-$342.0M-$290.5M
Diluted EPS$-1.61$-2.36$-2.79$-2.59
Total assets (year end)$621.3M$871.3M$844.0M$1.10B
Cash and equivalents (year end)$84.0M$124.3M$143.7M$151.8M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Relay Therapeutics, Inc.

Ticker
RLAY (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, MA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1812364

Frequently asked questions

What exchange is Relay Therapeutics, Inc. listed on?

Relay Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RLAY.

What industry is Relay Therapeutics, Inc. in?

Relay Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Relay Therapeutics, Inc. headquartered?

Relay Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.

When does Relay Therapeutics, Inc.'s fiscal year end?

Relay Therapeutics, Inc.'s fiscal year ends on December 31.

How much revenue did Relay Therapeutics, Inc. report?

Relay Therapeutics, Inc. reported $15.4M in revenue for calendar year 2025, according to its SEC filings.